dihexa for high blood pressure (PNB-0408) | c-Met/HGFR Activator Dihexa · Disguised Alpha

This comparison illustrates the gap between novel molecular mechanism discovery and validated clinical translation Dihexa represents frontier neuroscience with unresolved questions, while Cerebrolysin represents established but less mechanistically precise neurotrophic therapy

Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

The Journal of Pharmacology and Experimental Therapeutics issued an Expression of Concern in 2021 (PMID: 34551989) for the McCoy et al

Studied in models involving hepatocyte growth factor pathway activity, c-Met receptor signaling, and neurotrophic response systems

In lab experiments, they found that both drugs did their job, but KBP-336 was more powerful and leaned more towards activating one of the sensors over the other